Margot Blanchon
RWE Lead in Oncology Sanofi
Seminars
Thursday 11th February 2027
Using RWE to Inform Clinical Development & Designing Trials Around the Right Patients, Endpoints & Assumptions
9:30 am
- Leverage RWD earlier in clinical development to assess patient populations, inform inclusion and exclusion criteria, and ensure trial designs reflect real-world clinical practice
- Use real-world insights to challenge critical trial assumptions, from patient representativeness and stratification factors to expected treatment effects and endpoint selection
- Support evidence-based go/no-go decisions by identifying where RWD can strengthen Phase III planning
